Skip to main content

Table 7 Cox multivariate analysis for OS

From: Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

 

Overall survival (OS)

HR

(95% CI)

p-value

DCR axitinib

0.336

(0.192–0.590)

0.00015

Performance status

 ECOG 0

1

 

0.058

 ECOG 1

0.872

(0.183–4.160)

0.863

 ECOG 2

1.706

(0.359–8.108)

0.502

Heng score

 Good

1

 

0.025

 Poor

3.426

(1.374–8.541)

0.008

 Intermediate

2.057

(1.040–4.068)

0.038

Nephrectomy

 Yes

0.319

(0.153–0.664)

0.002

Istology

 Clear cell carcinoma

0.402

(0.149–1.079)

0.070

Gender

 Male

0.629

(0.371–1.066)

0.085

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us